Industry

Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Research 2025-2035 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, Type of Manufacturer and Geographical Region” report has been added to ResearchAndMarkets.com’s offering. The global viral vector manufacturing, non-viral vector manufacturing and gene therapy … [Read more…]

Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30

Conference Call and Webcast Scheduled for 1:30 p.m. PT ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release first quarter 2025 financial results after the market close on Wednesday, April 30, 2025. The … [Read more…]

Womed Launches Female Fertility Preserving Device in Europe

Womed Leaf®, the First Intrauterine Adhesion Barrier Film, to be distributed in 14 European Countries MONTPELLIER, France–(BUSINESS WIRE)–#femtech–Womed, the uterine health company developing innovative, safe and effective treatments to free women from uterine pathologies, today announced it has signed licensing agreements with Kebomed Europe and Saesco Medical to distribute its first medical device, Womed Leaf®, … [Read more…]

Fasikl Announces Breakthrough Pivotal Data Demonstrating Superiority of Felix NeuroAI Wristband over Sham Device for Essential Tremor

—Wristband is a first-of-its-kind investigational wearable designed to provide dynamic, all-day, personalized relief for people with essential tremor (ET); powered by advanced AI to continuously adapt stimulation based on real-time feedback— —TRANQUIL study results presented in late-breaker at the 2025 American Academy of Neurology (AAN) annual meeting demonstrate clinically meaningful improvements in ET symptoms and … [Read more…]

New Coalition Calls for Urgent Action to Address Rising Stroke Crisis

GENEVA–(BUSINESS WIRE)–#StrokeActionNow–Launching today, the world’s first multisector advocacy movement dedicated to stroke – the Global Stroke Action Coalition – has issued an urgent call to action to address growing inequities in stroke. Already a leading cause of death and disability, without intervention, the global burden of stroke is projected to rise by a further 50% … [Read more…]

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer1

Based on the Phase 3 CheckMate-8HW trial, Opdivo plus Yervoy demonstrated reduction in the risk of disease progression or death by 79% vs. chemotherapy in the first-line setting and by 38% vs. Opdivo monotherapy across all lines of therapy 1 The approval was granted more than two months ahead of the Prescription Drug User Fee … [Read more…]

Asset Value Investors Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage With Shareholders More Constructively

LONDON–(BUSINESS WIRE)–Asset Value Investors Limited (‘AVI’) launches a campaign calling for Rohto Pharmaceutical (‘Rohto’) to focus on its core businesses rather than allocating resources to the unsuccessful regenerative medicine business, and to engage with shareholders more constructively to comply with the Tokyo Stock Exchange’s (‘TSE’) request for management that is conscious of the cost of … [Read more…]

In-Vitro Fertilization Industry Report 2025-2033: Total Revenues to Exceed US$49 Billion by 2033 – Analysis of Regional Market Sizes and Shares of Major Players – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “In Vitro Fertilization Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033” has been added to ResearchAndMarkets.com’s offering. The IVF Market is expected to reach US$ 49.12 billion 2033 from US$ 26.43 billion in 2024, with a CAGR of 7.13% from 2025 to 2033. Growing rates of infertility, improvements in … [Read more…]

Laser Photonics & CMS Advance R&D Efforts in Laser Cold Marking for Plastic Medical Device Manufacturing

ORLANDO, Fla.–(BUSINESS WIRE)–Laser Photonics Corporation (NASDAQ: LASE) (“LPC”), a leading global developer of industrial laser systems for cleaning and other material processing applications, and its subsidiary, Control Micro Systems, Inc. (CMS Laser), announced a significant acceleration of their joint Research and Development (R&D) initiative focused on advanced Laser Cold Marking technology tailored specifically for the … [Read more…]

DATROWAY® Approved in the EU for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer

First approval in the EU for Daiichi Sankyo and AstraZeneca’s DATROWAY based on TROPION-Breast01 trial showing 37% reduction in the risk of disease progression or death versus chemotherapy Second DXd antibody drug conjugate approved in EU based on Daiichi Sankyo’s DXd technology TOKYO & MUNICH–(BUSINESS WIRE)–DATROWAY® (datopotamab deruxtecan) has been approved in the European Union … [Read more…]